Posted by Michael Wonder on 03 Jul 2023
‘Asthma care in Korea reminds me of Canada 8 years ago’
3 July 2023 - Korean-born expert in Canada stresses appropriate reimbursement for biological drugs.
In Korea, five biologics are approved by the Ministry of Food and Drug Safety to treat severe asthma. Still, only omalizumab (Zolair), a drug for allergic asthma, is covered by insurance, while all other interleukin inhibitors used to treat eosinophilic asthma are not reimbursed.
